Antimicrobial therapy for rheumatoid arthritis (Q40963943)

25 September 2017

1 reference

title

Antimicrobial therapy for rheumatoid arthritis (English)

1 reference

25 September 2017

Kloppenburg M

1

1 reference

25 September 2017

Dijkmans BA

series ordinal

2

1 reference

25 September 2017

Breedveld FC

series ordinal

3

1 reference

25 September 2017

publication date

1 November 1995

1 reference

Bailliere's clinical rheumatology

25 September 2017

published in

1 reference

25 September 2017

volume

9

1 reference

25 September 2017

issue

4

1 reference

25 September 2017

page(s)

759-769

1 reference

Study of sulphamethoxazole in rheumatoid arthritis

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

Co-trimoxazole in rheumatoid arthritis: a comparison with sulphapyridine

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

Phthalylsulphathiazole in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

Antibiotics and suppression of lymphocyte function in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

Effect of doxycycline on immune response in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

Tetracyclines and Host Defense Mechanisms: Interference with Leukocyte Chemotaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

Mitochondrial biogenesis during the activation of lymphocytes by mitogens: the immunosuppressive action of tetracyclines

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

Randomised, double blind, placebo controlled trial of inosine pranobex in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

Rheumatoid knee synovitis successfully treated with intra-articular rifamycin SV.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

Prevention of appearance of radiological lesions in early rheumatoid arthritis: a randomized, single-blind study comparing intra-articular rifamycin with auranofin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

Effect of tetracyclines which have metalloproteinase inhibitory capacity on basal and heparin-stimulated bone resorption by chick osteoclasts

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

Treatment of early rheumatoid arthritis with rifampicin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

Immunomodulating effects of antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

Natural history of arthritis following venereal urethritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

Effect of antibiotics of chemotaxis of human leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

Report on chloroquine and dapsone in the treatment of rheumatoid arthritis: a 6-month comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

The inhibition of incorporation of leucine into protein of cell-free systems from rat liver and Escherichia coli by chlortetracycline

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

Early antibiotic treatment of reactive arthritis associated with enteric infections: clinical and serological study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

Suppression of human neutrophil functions by tetracyclines

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

Influence of tetracyclines on human polymorphonuclear leukocyte function

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

Minocycline reduces gingival collagenolytic activity during diabetes. Preliminary observations and a proposed new mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

Tetracyclines inhibit tissue collagenase activity. A new mechanism in the treatment of periodontal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

Further evidence that tetracyclines inhibit collagenase activity in human crevicular fluid and from other mammalian sources

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

Outcome of attempts to treat rheumatoid arthritis with gold, penicillamine, sulphasalazine, or dapsone

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

Thalidomide a promising new treatment for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

A double-blind comparative study of hydroxychloroquine and dapsone, alone and in combination, in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

A double-blind comparative study of metronidazole and placebo in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

Modulation of the proliferative response of murine thymocytes stimulated by IL-1, and enhancement of IL-1β secretion from mononuclear phagocytes by tetracyclines

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

The effects of minocycline and tetracycline on the mitotic response of human peripheral blood-lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

Minocycline in active rheumatoid arthritis. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

The Anticollagenolytic Potential of Lymecycline in the Long‐Term Treatment of Reactive Arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

Rifamycin SV versus triamcinolone in local treatment of rheumatoid synovitis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

Double blind, placebo controlled study of metronidazole as a disease modifying agent in the treatment of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

Inhibitory effect of minocycline on in vitro invasion and experimental metastasis of mouse renal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

Effect of antibiotics on the generation of reactive oxygen species

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

Ciprofloxacin and rheumatoid arthritis--lack of effect

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

The role of the MA-sensitive leukocyte chemotaxis in rheumatoid arthritis. A randomized double-blind clinical trial of griseofulvin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

Which component of sulphasalazine is active in rheumatoid arthritis?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

Reactive oxygen species activate and tetracyclines inhibit rat osteoblast collagenase

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

Blocking periodontal disease progression by inhibiting tissue-destructive enzymes: a potential therapeutic role for tetracyclines and their chemically-modified analogs.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

Interleukin-1 production by antibiotic-treated human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

False-negative N.B.T. tests due to transient malfunction of neutrophils.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

Clinical pharmacokinetics of doxycycline and minocycline

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

Immunosuppressive potential of antimalarials

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

Tetracycline administration increases collagen synthesis in osteoblasts of streptozotocin-induced diabetic rats: a quantitative autoradiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

Tetracycline in the treatment of rheumatoid arthritis. A double blind controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

Double-blind trial of dapsone against placebo in the treatment of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

5-Aminosalicylic acid or sulphapyridine. Which is the active moiety of sulphasalazine in rheumatoid arthritis?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

Inhibition of epithelial cell matrix metalloproteinases by tetracyclines

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

Effect of antimicrobial agents on human polymorphonuclear leukocyte microbicidal function

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

Clotrimazole in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycycline

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980312-7

7 January 2021

10.1016/S0950-3579(05)80312-7

Identifiers

DOI

1 reference

25 September 2017

1 reference